PCN22 COST-EFFECTIVENESS OF SUNITINIBAS SECOND LINE TREATMENT IN PATIENTS WITH METASTATIC RENAL CANCER IN BELGIUM
Abstract
Authors
F Van Nooten S Dewilde S Van Belle S Marbaix
F Van Nooten S Dewilde S Van Belle S Marbaix
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now